109 related articles for article (PubMed ID: 17710839)
1. Is the Migraid device an asset in the non-pharmacologic treatment of migraine?
Pieterse H; Kuster JA; Van Bortel LM
Acta Neurol Belg; 2007 Jun; 107(2):40-6. PubMed ID: 17710839
[TBL] [Abstract][Full Text] [Related]
2. Treatment of migraine attacks by compression of temporal superficial arteries using a device.
Cianchetti C; Cianchetti ME; Pisano T; Hmaidan Y
Med Sci Monit; 2009 Apr; 15(4):CR185-8. PubMed ID: 19333203
[TBL] [Abstract][Full Text] [Related]
3. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
5. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
Silberstein SD; Mannix LK; Goldstein J; Couch JR; Byrd SC; Ames MH; McDonald SA; Lener SE; Toso C
Neurology; 2008 Jul; 71(2):114-21. PubMed ID: 18606965
[TBL] [Abstract][Full Text] [Related]
6. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
7. Acupuncture for treating acute attacks of migraine: a randomized controlled trial.
Li Y; Liang F; Yang X; Tian X; Yan J; Sun G; Chang X; Tang Y; Ma T; Zhou L; Lan L; Yao W; Zou R
Headache; 2009 Jun; 49(6):805-16. PubMed ID: 19438740
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
Aurora SK; Rozen TD; Kori SH; Shrewsbury SB
Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
[TBL] [Abstract][Full Text] [Related]
11. A clinical study of migraine evolution.
Pryse-Phillips W; Aubé M; Bailey P; Becker WJ; Bellavance A; Gawel M; Giammarco R; Mackie G; Purdy RA; Robinson G; Shapero G; Wilson K
Headache; 2006; 46(10):1480-6. PubMed ID: 17115980
[TBL] [Abstract][Full Text] [Related]
12. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
Alemdar M; Pekdemir M; Selekler HM
Clin Ther; 2007 Jul; 29(7):1441-7. PubMed ID: 17825695
[TBL] [Abstract][Full Text] [Related]
13. Compression of superficial temporal arteries by a handmade device: a simple way to block or attenuate migraine attacks in children and adolescents.
Cianchetti C; Serci MC; Pisano T; Ledda MG
J Child Neurol; 2010 Jan; 25(1):67-70. PubMed ID: 19525492
[TBL] [Abstract][Full Text] [Related]
14. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.
Spierings EL; Keywood C
Pain Med; 2009; 10(4):633-8. PubMed ID: 19453958
[TBL] [Abstract][Full Text] [Related]
15. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
Freitag F; Taylor FR; Hamid MA; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500
[TBL] [Abstract][Full Text] [Related]
16. Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
Nett R; Mannix LK; Mueller L; Rodgers A; Hustad CM; Skobieranda F; Ramsey KE
Headache; 2008 Sep; 48(8):1194-201. PubMed ID: 18422606
[TBL] [Abstract][Full Text] [Related]
17. Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia.
Schoenen J; De Klippel N; Giurgea S; Herroelen L; Jacquy J; Louis P; Monseu G; Vandenheede M;
Cephalalgia; 2008 Oct; 28(10):1095-105. PubMed ID: 18644036
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
Chen LC; Ashcroft DM
Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
[TBL] [Abstract][Full Text] [Related]
19. Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
Cady RK; Freitag FG; Mathew NT; Elkind AH; Mao L; Fisher AC; Biondi DM; Finlayson G; Greenberg SJ; Hulihan JF
Headache; 2009 Mar; 49(3):350-63. PubMed ID: 19220503
[TBL] [Abstract][Full Text] [Related]
20. Acupuncture in migraine prevention: a randomized sham controlled study with 6-months posttreatment follow-up.
Alecrim-Andrade J; Maciel-Júnior JA; Carnè X; Severino Vasconcelos GM; Correa-Filho HR
Clin J Pain; 2008 Feb; 24(2):98-105. PubMed ID: 18209514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]